Treadwell
  • About
  • Science
  • Pipeline
  • News
  • Connect
Select Page

News & Events

Treadwell-HPK1-inhibitor-IND-Approval

Jun 2, 2020

Treadwell Therapeutics Announces US FDA Clearance of IND Application for Phase 1/2 Study of HPK1 Inhibitor, CFI-402411

Jefferies Virtual Healthcare Conference

Jun 1, 2020

Jefferies 2020 Virtual Healthcare Conference

June 4, 2020 at 4:30 pm ET

Listen to webcast
©2020 Treadwell Therapeutics
Terms of Use / Privacy Policy
Site by D&CO
New York Office
411 Lafayette Street, 6th Floor New York, New York, USA 10003

Whos theme My Theme | Powered by MyPress | Designed by Your Design Agency